On June 24, 2025, Rhythm Pharmaceuticals, Inc. held its Annual Meeting where stockholders approved an amendment to the company's Certificate of Incorporation to enhance officer exculpation provisions, and the amendment was filed on June 25, 2025. A total of 60,718,627 votes were present, and key proposals including the election of directors and the amendment were approved.